Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of MYL-1401A vs Humira in Chronic Plaque Psoriasis
NCT02714322Phase 3Completed
- Sponsor
- Mylan
- Start
- Jun 2015
- Primary completion
- May 2016
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Mylan. Started Jun 2015; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02714322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02714322.